---
title: "Phenylalanine (Phe) Controls Diverse Plant Pathogens Across Mono- and Dicot Crops"
id: "biorxiv-13-phenylalanine-treatment-suppresses-necrotrophic-and-biotrophic-pathogens-in"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-13-phenylalanine-treatment-suppresses-necrotrophic-and-biotrophic-pathogens-in"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1?rss=1"
published_at: "2026-07-27T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Phenylalanine (Phe) Controls Diverse Plant Pathogens Across Mono- and Dicot Crops
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-13-phenylalanine-treatment-suppresses-necrotrophic-and-biotrophic-pathogens-in
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1?rss=1)
- **Published At:** 2026-07-27T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Exogenous L-**phenylalanine (Phe)** applied as foliar spray or root drench reduced disease severity across a wide range of pathosystems in both monocot and dicot species. - Effective activity was consistently observed at concentrations ≥4 mM. - Pathogen groups suppressed included necrotrophic and biotrophic fungi, oomycetes, bacterial pathogens and a virus. - Specific fungi and oomycetes tested: **Botrytis cinerea**, **Sclerotinia sclerotiorum**, powdery mildews (Leveillula taurica, Oidium neolycopersici, Podosphaera xanthii), wheat foliar pathogens (Blumeria graminis f. sp. tritici, Zymoseptoria tritici, Puccinia triticina, P. striiformis f. sp. tritici), **Pseudoperonospora cubensis**, and **Pythium aphanidermatum**. - Bacterial pathogens evaluated included **Pseudomonas syringae pv. tomato** and **Clavibacter michiganensis** subsp. michiganensis; a tobamovirus (Tomato brown rugose fruit virus, ToBRFV) was also reduced. - Crop systems tested ranged from greenhouse and commercial-like conditions in petunia, chrysanthemum, determinant and indeterminate tomato, sweet basil, cucumber, lettuce, wheat and other dicots. - Phe was active on both young and mature leaves and often provided control comparable to chemical fungicides under the tested conditions. - Combining Phe with other fungicides rarely improved control, except an enhanced activity with pyrimethanil against **B. cinerea** in tomato. - Synergy observed when Phe was mixed with an adjuvant against tomato powdery mildews; a formulated product (NaturaFend 550 SP) outperformed non-formulated Phe for **B. cinerea** (tomato) and **P. xanthii** (cucumber). - Timing mattered: application 5 days before infection gave better protection than treatments at 0, 3, or 7 days before infection. - The study is a preprint and has not undergone peer review; authors declared no competing interests. - Details beyond the abstract (e.g., experimental protocols, statistical measures, exact disease reduction percentages) were not reported in the provided source text.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=3vXe5XeBVO3PZEjHcXVbMQH85Dh9VbOLCh48TV68YoI-1785211500.6961641-1.2.1.1-JmD0h5ahtJCBjQZStWKKWHnLDUfdBWUW3ohBOtpG1Sk) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Phenylalanine Treatment Suppresses Necrotrophic and Biotrophic Pathogens in Mono- and Dicotyledonous Plants [ View ORCID Profile](http://orcid.org/0000-0001-9000-8214)Yigal Elad, Dalia Rav-David, [ View ORCID Profile](http://orcid.org/0000-0002-7646-9492)Michal Oren-Shamir doi: https://doi.org/10.64898/2026.07.26.740754 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Yigal Elad Volcani Institute * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yigal%2BElad%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Elad%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYigal%2BElad%2B) * [ORCID record for Yigal Elad](http://orcid.org/0000-0001-9000-8214 "Open in new tab") * For correspondence: elady@volcani.agri.gov.il Dalia Rav-David Volcani Institute * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dalia%2BRav-David%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Rav-David%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADalia%2BRav-David%2B) Michal Oren-Shamir Volcani Institute * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michal%2BOren-Shamir%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Oren-Shamir%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMichal%2BOren-Shamir%2B) * [ORCID record for Michal Oren-Shamir](http://orcid.org/0000-0002-7646-9492 "Open in new tab") * [Abstract](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5657690/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5657690/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5657690/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5657690/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5657690/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract L-phenylalanine (Phe) is converted via the phenylpropanoid pathway into phenolic compounds, and elevated phenolic/flavonoid levels are generally associated with enhanced plant resistance. We previously showed that exogenous Phe suppresses the necrotrophic fungus Botrytis cinerea in petunia, chrysanthemum, determinant tomato, and several postharvest diseases. Here, we expanded evaluation to a broad range of pathosystems, including an indeterminate greenhouse tomato cultivar, multiple dicot species, and the monocot wheat. Phe, applied as spray or drench across concentrations, was consistently effective at ≥4 mM. It reduced disease severity in diverse systems: Sclerotinia sclerotiorum (tomato, sweet basil, cucumber, lettuce), Leveillula taurica and Oidium neolycopersici (tomato), Podosphaera xanthii (cucumber), wheat foliar pathogens (Blumeria graminis f. sp. tritici, Zymoseptoria tritici, Puccinia triticina, P. striiformis f. sp. tritici), the oomycetes Pseudoperonospora cubensis (cucumber leaves) and Pythium aphanidermatum (roots), bacterial pathogens (Pseudomonas syringae pv. tomato and Clavibacter michiganensis subsp. michiganensis) and Tomato brown rugose fruit (ToBRFV) that belongs to the Tobamovirus genus. Phe was effective on both young and mature leaves and often performed comparably to chemical fungicides; combinations rarely improved control, except for enhanced activity with pyrimethanil against B. cinerea in tomato. Synergistic effects were observed when Phe was combined with an adjuvant against tomato powdery mildews. A formulated product (NaturaFend 550 SP) was more effective than non-formulated Phe in B. cinerea (tomato) and P. xanthii (cucumber). Application timing also influenced efficacy, with treatment 5 days before infection providing superior control compared with 0, 3, or 7 days. Overall, Phe effectively controlled biotrophic and necrotrophic fungi, oomycetes, bacterial pathogens and a virus across diverse crops under experimental greenhouses and commercial like conditions. ### Competing Interest Statement The authors have declared no competing interest. Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.07.26.740757v1 "The micro-plant remains preserved on lithics and in the associated sediment of the Hoabinhian Laang Spean cave site, Battambang province, Cambodia.")[Next ](https://www.biorxiv.org/content/10.64898/2026.07.26.740768v1 "TAS2R10 Suppresses ABCG2 Transporter-Associated Chemoresistance and Enhances Cisplatin Sensitivity in Head and Neck Squamous Cell Carcinoma") Posted July 27, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/07/27/2026.07.26.740754.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.07.26.740754v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Phenylalanine Treatment Suppresses Necrotrophic and Biotrophic Pathogens in Mono- and Dicotyledonous Plants Yigal Elad, Dalia Rav-David, Michal Oren-Shamir bioRxiv 2026.07.26.740754; doi: https://doi.org/10.64898/2026.07.26.740754 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.07.26.740754v1%26text%3DPhenylalanine%2520Treatment%2520Suppresses%2520Necrotrophic%2520and%2520Biotrophic%2520Pathogens%2520in%2520Mono-%2520and%2520Dicotyledonous%2520Plants "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.07.26.740754v1%26t%3DPhenylalanine%2520Treatment%2520Suppresses%2520Necrotrophic%2520and%2520Biotrophic%2520Pathogens%2520in%2520Mono-%2520and%2520Dicotyledonous%2520Plants "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.07.26.740754v1%26title%3DPhenylalanine%2520Treatment%2520Suppresses%2520Necrotrophic%2520and%2520Biotrophic%2520Pathogens%2520in%2520Mono-%2520and%2520Dicotyledonous%2520Plants%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.07.26.740754v1%26title%3DPhenylalanine%2520Treatment%2520Suppresses%2520Necrotrophic%2520and%2520Biotrophic%2520Pathogens%2520in%2520Mono-%2520and%2520Dicotyledonous%2520Plants "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.07.26.740754) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.07.26.740754v1&count=horizontal&via=&text=Phenylalanine%20Treatment%20Suppresses%20Necrotrophic%20and%20Biotrophic%20Pathogens%20in%20Mono-%20and%20Dicotyledonous%20Plants&counturl=www.biorxiv.org/content/10.64898/2026.07.26.740754v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (7828) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (18293) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (14469) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (43298) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22065) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (19171) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (26285) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (13691) * [Ecology](https://www.biorxiv.org/collection/ecology) (20496) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (24954) * [Genetics](https://www.biorxiv.org/collection/genetics) (15905) * [Genomics](https://www.biorxiv.org/collection/genomics) (23096) * [Immunology](https://www.biorxiv.org/collection/immunology) (18289) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (41500) * [Molecular Biology](https://www.biorxiv.org/collection/molecular-biology) (17605) * [Ne
## Related Clinical Research

- [Pollen size shifts after whole genome duplication in autotetraploids](https://medichelpline.com/clinical-feed/biorxiv-17-biased-evolution-of-pollen-size-after-whole-genome-duplication.md)
- [Chemosensory System Evolution in Actinomycetota: Polyphyly and Lineage-Specific Expansion](https://medichelpline.com/clinical-feed/biorxiv-5-polyphyletic-origins-and-lineage-specific-expansion-of-chemosensory-systems-in.md)
- [Correction: Updated Data Availability DOI for Bone-Conducted Ultrasonic ABR Study in Cisplatin Hea](https://medichelpline.com/clinical-feed/plos-one-2-correction-bone-conducted-ultrasonic-auditory-brainstem-response-thresholds-in.md)
- [Bone-Conducted Ultrasonic Auditory Brainstem Response and Cisplatin-Induced Hearing Loss in Mice](https://medichelpline.com/clinical-feed/plos-one-8-bone-conducted-ultrasonic-auditory-brainstem-response-thresholds-in-a-mouse.md)
- [Arts engagement and global wellbeing: Outcome-wide analysis from 22 countries](https://medichelpline.com/clinical-feed/medrxiv-9-the-health-and-wellbeing-impact-of-arts-engagement-a-longitudinal-outcome-wide.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.